Protein may hold promise for diabetes treatment

03/29/2012 | Yahoo!

Researchers at the Gladstone Institutes found that mice genetically engineered to lack a protein called p75 neurotrophin receptor had better insulin response when fed with a normal diet. The mice also showed higher glucose absorption in response to insulin compared with normal mice when the action of the p75NTR protein was blocked in fat cells. "Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes," researcher Katerina Akassoglou reported in the Proceedings of the National Academy of Sciences.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX